Back to User profile » Professor Erminia Ridolo
Papers published by Professor Erminia Ridolo:
Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide
Ridolo E, Pellicelli I, Gritti B, Incorvaia C
Patient Preference and Adherence 2019, 13:145-150
Published Date: 14 January 2019
Two decades with omalizumab: what we still have to learn
Incorvaia C, Mauro M, Makri E, Leo G, Ridolo E
Biologics: Targets and Therapy 2018, 12:135-142
Published Date: 26 October 2018
Striving for optimal bronchodilation: focus on olodaterol
Incorvaia C, Montagni M, Makri E, Riario-Sforza GG, Ridolo E
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:439-444
Published Date: 1 March 2016
New combinations in the treatment of COPD: rationale for aclidinium–formoterol
Incorvaia C, Montagni M, Makri E, Ridolo E
Therapeutics and Clinical Risk Management 2016, 12:209-215
Published Date: 15 February 2016
New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]
Frati F, Cecchi L, Scala E, Ridolo E, Dell'Albani I, Makrì E, Pajno GB, Incorvaia C
Biologics: Targets and Therapy 2015, 9:45-46
Published Date: 29 June 2015
New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis
Frati F, Cecchi L, Scala E, Ridolo E, Dell'Albani I, Makrì E, Pajno G, Incorvaia C
Biologics: Targets and Therapy 2014, 8:221-226
Published Date: 12 September 2014
Omalizumab, an anti-immunoglobulin E antibody: state of the art
Incorvaia C, Mauro M, Russello M, Formigoni C, Riario-Sforza GG, Ridolo E
Drug Design, Development and Therapy 2014, 8:197-207
Published Date: 7 February 2014
Role of indacaterol and the newer very long-acting β2-agonists in patients with stable COPD: a review
Ridolo E, Montagni M, Olivieri E, Riario-Sforza GG, Incorvaia C
International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:425-432
Published Date: 18 September 2013